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without any adverse reactions. The expected outcome was to for-
mulate an educational tool for nurses to instruct proper dosage
parameters, dose adjustment requirements, and side effects to be
aware of. An algorithm was created and posted in the nursing
medication room and handouts were printed for patients and
families with a list of possible adverse effects of the BAD drip. With
the knowledge of additional anti-emetic therapies, pediatric BMT
nurses will be better prepared to act on behalf of their BMT
population experiencing intractable nausea and vomiting.
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RE-EVALUATING A PATIENT SAFETY PROGRAM IN AN ONCOLOGY
NURSING SETTING
Marzan, A.B., Canlas, D., Cooke, S., Gerst, J., Nguyen, M.-L., Page-
Pettus, L. University of Texas M.D.Anderson Cancer Center, Houston,
TX
Keeping a patient safe and free from falls in the hospital setting
is an ongoing challenge for nurses and the health care team.
Therefore, fall prevention is a major component of our institu-
tion’s oncology patient safety program.
In the literature, the majority of studies address falls in persons
over the age of 70. Our patient population with cancer is younger,
35 to 60 years old, and has other factors involved; the disease
process itself, medications, weakness and fatigue, to name a few.
We decided to ﬁrst deﬁne our patient population’s risk factors and
then develop a program that would decrease falls within the
younger, oncology population.
Our plan included identifying patients at risk, revising our policy,
enhancing assessment and reassessment methods, providing new
visual alerts for patients at risk, and upgrading staff, patient and
family education programs.
These changes were piloted on 8 inpatient units for one month.
No falls were reported during this time frame. After the successful
pilot, over 1,500 health care workers received training to the
revised patient safety plan. The program was then implemented
house-wide. It was thought that these changes would continue to
eliminate falls.
However, outcome metrics, utilizing institutional incident re-
ports, indicated otherwise. Data analysis revealed no house-wide
culture change occurred. The number of inpatient falls/1,000 hos-
pital days remained the same as before the pilot.
The nursing staff on 3 leukemia units then decided to utilize a
simple Quality Improvement tool, the “OOPS Monitor” (Oppor-
tunity for Outstanding Patient Safety) to gather data. This data
revealed multi-factorial root causes underlying modest policy com-
pliance.
These results were shared with the nursing staff through focus
groups where additional data was collected. The staff identiﬁed
several issues related to non-use of the program elements. Each of
the 3 units was asked to develop an action plan in response to the
data. These action plans resulted in the implementation of a Mul-
tidisciplinary Fall Prevention Consult Team whose goal is to mon-
itor compliance and keep safety awareness at a maximum level.
Monthly monitoring will continue with timely feedback to unit
staff members and the institution.
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AN EMERGING CHALLENGE: NURSING SKIN CARE OF BONE MARROW
TRANSPLANT PATIENTS WITH MYCOSIS FUNGOIDES
Huynh, C.D., Mishaw, K., Neumann, J., Donato, M. The University of
Texas M.D. Anderson Cancer Center, Houston, TX
Nursing skin care for Mycosis Fungoides (MF)/ Sezary Syn-
drome patients has always been a challenge because of the risk of
chronic skin infection with staph species and subsequent systemic
infections.
Mycosis Fungoides/ Sezary Syndrome is a cutaneous T-cell lym-
phoma. Its clinical skin involvement is often initially mistaken for
eczema, psoriasis, or other types of T-cell lymphomas. The disease
remains indolent for many years before actual diagnosis. The
prognosis of these patients is based on the extent of disease at its
stage. Among various topical and systemic therapies, bone marrow
transplant emerges recently as a non-conventional treatment op-
tion. Because of the scarcity of BMT experience with patients who
have MF, standardized nursing guidelines for skin care in these
patients are yet established. Additional challenges arise, when
BMT patients face the complications of skin Graft-versus-Host
Disease (GVHD).
The Bone Marrow Transplant (BMT) department of our center
identiﬁed the nursing responsibility with skin care for these pa-
tients to establish the standard of nursing skin care for these
patients that is most effective. Generally, this program reviews the
clinical manifestations of the Mycosis Fungoides, its conventional
and non-conventional treatments, including BMT. Speciﬁcally, it
analyzes BMT patients with MF at our institution, focusing on
various nursing skin care methods, including sterile Central Ve-
nous Catheter dressing change techniques. A case study will also be
presented. In addition, the project informs current clinical trials
and examines the research at our institution that focuses on estab-
lishing BMT protocols for MF patients. The effectiveness of nurs-
ing skin care is measured by progressive healing of tissues and
decrease in the size of lesions, effective application of combination
of dressings, infection control, pain management, and the quality
of life of these patients.
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A REFERENCE GUIDE TO SEAMLESS CARE: THE BLOOD AND MARROW
TRANSPLANT COORDINATOR ORIENTATION MANUAL
Morse, R., Smith, B., Calamusa, J., Brion, C., Trulock, J., Harris, S.
UTMD Anderson Cancer Center, Houston, TX
Transitioning the blood and marrow transplant (BMT) patient
from the outpatient clinic to the inpatient setting in a large com-
prehensive cancer center can be a challenging and complex process.
M. D. Anderson Cancer Center BMT Department performs over
600 transplants each year, including autologous, allogeneic, and
sygeneic transplants. Currently, the transplant center employs ﬁve
related BMT coordinators. Each coordinator is responsible for
multiple physicians working with different diseases. The coordi-
nators deal with various diseases, hence, work-ups range from the
very simple patient evaluation and assessment to the complex
patient. Because of the variety of tests necessary, it was found that
work-ups were not always 100% complete. From there it was
determined that in order to provide consistent, accurate informa-
tion the ﬁrst time around, a resource manual was needed for the
current coordinators and new coordinators to utilize as a reference.
This would also help facilitate a simpler way of verifying what was
needed for each individualized patient work-up.
The reference evolved into the BMT Coordinator Orientation
Manual. The manual outlines each test needed for a speciﬁc disease
process. This is done using written instructions and sample work-
ups. The manual includes instructions for HLA typing of patient/
normal donor, donor work-ups, as well as detailed work-ups for
patients with various disease processes. The job description for the
BMT Nurse Transplant Coordinator and the policies and proce-
dures referring to the patient’s pre-transplant coordination process
are also included.
The manual is used on a regular basis by the coordinators to
provide consistent, accurate information without having to dupli-
cate orders on the same patient. Insisting on consistent, accurate
information aids in a seamless BMT admission process for the
transplant patient.
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LEADING LEADERS AT ONE OF THE LARGEST TRANSPLANT PROGRAMS
IN THE COUNTRY
Adornetto, D., Stary, S.J., Sorensen, S., Neumann, J., Johnston, P.
UTMD Anderson Cancer Center, Houston, TX
The Blood and Marrow Transplant patient’s journey through a
blood and marrow transplant program should be a seamless tran-
sition from the community, to the outpatient setting, to the inpa-
tient unit and back to the outpatient center. The various processes
that enable the journey to occur without interruption are one of
the many responsibilities of the leadership team. On a weekly basis,
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the leaders of the transplant process from the apheresis clinic,
outpatient center, inpatient unit, advanced practice nurse program,
the business manager, and the BMT Business Center meet to
discuss operational issues with the Clinical Administrative Director
(CAD) and the Center Medical Director. Various operational is-
sues across all patient care areas such as daily clinic ﬂow, laboratory
issues, patient discharge issues, and patient education are discussed.
Administrative issues and progress regarding quality improvement
projects are also shared. Weekly meetings encourage the commu-
nication of ideas, provide mutual understanding of each other’s
operations, enhance collaborative plans to improve patient care
and assure follow-through of projects.
Once a month the Department Medical Chairman joins the
leadership team to review ﬁnancials and other pertinent opera-
tional faculty issues. The leadership team also uses this time to
collaborate with other areas in the institution where the BMT
patients are cared for i.e.: the leaders from the Ambulatory Treat-
ment Center join us to discuss operational issues and Physician
Referral Services have joined the team to discuss ways to improve
our relationships with referring physicians. A weekly agenda and
minutes are generated by the CAD and the Administrative Assis-
tant to keep the team focused and directed. The CAD also meets
individually with the managers of the inpatient unit, outpatient
center, and apheresis clinic, as well as, the leaders from the business
center area on a weekly to monthly basis to discuss speciﬁc unit
operational and quality assurance issues as needed. Success is mul-
tifaceted. The team needs to be able to trust each other so as to
negotiate issues that result in outcomes within the team that com-
pliment the entire program. Recognizing and growing the leaders
within the team is important to the dynamics of a program. En-
couraging the building of relationships and creating a culture that
supports the ownership of program outcomes is key to building and
empowering leadership.
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TEAMBUILDING: COMPLEXITY AND CHALLENGE IN ONE OF THE LARG-
EST TRANSPLANT PROGRAMS IN THE COUNTRY
Stary, S.J.1, Adornetto, D.1, Sorensen, S.1, Cruz, E.1, Lyon, V.2 1. UT
MD Anderson Cancer Center, Houston, TX; 2. The Lyon-Group, Hous-
ton, TX
The challenge of developing teambuilding in one of the largest
Blood and Marrow Transplant programs in the country includes
the complexity of the patient’s needs, geographical vastness of the
institution, and the organizational/operational needs of the pro-
gram and Center. The multidisciplinary teams involved in the
patient’s care in the outpatient area include the center nurses,
patient service coordinators, transplant clinical coordinators, pa-
tient access specialists, and patient access coordinators. The mem-
bers of the outpatient transplantation team had developed relation-
ships and silos within their own individual teams in an effort to
provide care to the transplant patient. This has lead to ineffective
collaboration with other team members within the center. A de-
partmental climate survey was administered to all staff members to
measure the effective teamwork amongst members. The results
indicated the need for Centerwide teambuilding, in an effort to
re-establish effective collaboration and trust within and between
the teams.
The administrative team enlisted the services of an outside facil-
itator to assess, coach, and assist in developing techniques to
reestablish communication and trust. Teams were introduced to
the teambuilding concept in a staff meeting resulting in the estab-
lishment of team meetings. A baseline Team Effectiveness Proﬁle
was administered. Each team then participated in the following
workshops; Team behavioral Styles, Team Communication, Team
Conﬂict, and Unblocking Your Team/Managing Change.
The positive feedback from the team members led the BMT
leadership team to establish additional workshops. This has lead to
open communication between the teams and has provided im-
proved collaboration in process improvement projects as evidenced
by observations of daily interaction of staff members.
The next step is to reassess the effectiveness of the workshops
using the Team Effectiveness Proﬁle. The positive feedback from
the staff involved led the administrative staff to continue to pursue
additional workshops within cross-functional teams.
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A REVIEW OF CYTOMEGALOVIRUS INFECTIONS FOLLOWING NONMY-
ELOABLATIVE ALLOGENEIC STEM CELL TRANSPLANTS USING CAM-
PATH-1H
Thompson, M., Catlin, C., Rizzieri, D. Duke University Medical Center
Adult Bone Marrow Transplant Center, Durham, NC
The ﬁrst cytomegalovirus (CMV) strain was isolated in cell
cultures in 1956. Since that time, there have been many studies
showing that CMV is one of the most common and potentially life
threatening viral infections in immunosuppressed patients. CMV
disease leads to increased morbidity and mortality rates in bone
marrow transplant patients. Thanks to advancing technology, test-
ing for CMV on the DNA level has enabled us to assess viral loads
and CMV reactivation prior to the onset of CMV disease. The
availability of new antiviral medications has also enabled us to
initiate preemptive antiviral therapy when CMV DNA is ﬁrst
detected. This early detection and treatment has led to a decrease
in end-organ CMV disease and overall mortality from CMV re-
lated infections. Nonmyeloablative stem cell transplantation is a
less toxic approach to allogeneic transplants. Using chemotherapy
regimens with less acute toxicity provide the beneﬁts of allogeneic
stem cells and graft versus malignancy effect to patients who may
not otherwise tolerate a full myeloablative chemotherapy regimen.
This poster will review the incidence and time of onset of CMV
viremia in 125 adult patients participating in a clinical trial using a
nonmyeloablative preparative regimen of 2 grams Cyclophospha-
mide and Fludarabine along with Campath-1H for T-cell deple-
tion of the patient and their donor. This regimen was followed by
allogeneic peripheral stem cell transplant from a matched or mis-
matched donor. Developing a standard for antiviral prophylaxis
post allogeneic stem cell transplantation provides a unique chal-
lange to our health care team and is an area that needs further
research in all transplant centers.
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PATIENT SATISFACTION: DECREASING THE PATIENT “WAIT TIME” IN
THE AMBULATORY CARE SETTING
Savoie, J., Stary, S., Adornetto, D., Evans, K., Peck, N. University of
Texas MD Anderson Cancer Center, Houston, TX
The Blood and Marrow Transplantation patient satisfaction tool
provides a variety of information regarding the patient’s perception
of their health care and members of the health care team. The
rationale for the development of this monthly patient satisfaction
tool was to provide data concerning the perception of the patient
regarding the quality of care, courtesy, efﬁciency of the staff, and
general clinic operations. The patient completes the survey based
on a (1-5) Likert scale. The results of this survey have demon-
strated patient wait time scores with an average of 2.7 out of 5 in
2002 as the primary need for improvement.
In an effort to decrease patient wait time, a task force of staff
members in collaboration with clinic administration, was formed to
determine reasons for lengthy patient wait times and to develop
strategies for improvement. The task force meetings provided the
staff with a sense of ownership in addressing an operational issue.
The task force evaluated and revised the original survey tool,
which was a combined tool for the BMT Center and Apheresis
Clinic. The tool was revised to reﬂect one clinical area. Corrective
actions developed were the standardization of distribution, revision
of physician appointment templates to reﬂect clinic ﬂow, develop-
ment of daily comment cards, informing patient of the reason for
delay, and providing patient with a pager so they may utilize their
time more effectively. Continued monitoring over the ﬁrst 6
months of this year demonstrated little improvement. Therefore,
additional efforts were instituted to decrease the patient’s percep-
tion of their wait time with the implementation of the “15 minute
rule” by speaking with patients regarding their delay, constant
discussion with the staff, administrative rounds through the recep-
tion area speaking with patients, and placards distributed through-
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